Journal
NATURE REVIEWS CANCER
Volume 10, Issue 7, Pages 489-503Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2875
Keywords
-
Categories
Funding
- Cancer Research UK [23, 158/A7536]
Ask authors/readers for more resources
There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer. S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival. This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase. This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available